Rectal toxicity and rectal dosimetry in low-dose-rate 125I permanent prostate implants: A long-term study in 1006 patients
- 30 June 2012
- journal article
- Published by Elsevier BV in Brachytherapy
- Vol. 11 (3), 199-208
- https://doi.org/10.1016/j.brachy.2011.05.007
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Brachytherapy for the Treatment of Prostate CancerThe Cancer Journal, 2007
- Rectal toxicity profile after transperineal interstitial permanent prostate brachytherapy: Use of a comprehensive toxicity scoring system and identification of rectal dosimetric toxicity predictorsInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Factors predictive of rectal bleeding after 103Pd and supplemental beam radiation for prostate cancerBrachytherapy, 2004
- Perirectal seeds as a risk factor for prostate brachytherapy-related rectal bleedingInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomesSeminars in Radiation Oncology, 2002
- Dosimetric and radiographic correlates to prostate brachytherapy-related rectal complications.International Journal of Cancer, 2001
- 10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Defining the risk of developing Grade 2 proctitis following 125I prostate brachytherapy using a rectal dose–volume histogram analysisInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 1995